Attached files
| file | filename |
|---|---|
| EX-10.19 - EX-10.19 - Verrica Pharmaceuticals Inc. | d361077dex1019.htm |
| EX-10.18 - EX-10.18 - Verrica Pharmaceuticals Inc. | d361077dex1018.htm |
| EX-10.5 - EX-10.5 - Verrica Pharmaceuticals Inc. | d361077dex105.htm |
| EX-10.4 - EX-10.4 - Verrica Pharmaceuticals Inc. | d361077dex104.htm |
| EX-5.1 - EX-5.1 - Verrica Pharmaceuticals Inc. | d361077dex51.htm |
| EX-3.1 - EX-3.1 - Verrica Pharmaceuticals Inc. | d361077dex31.htm |
| EX-1.1 - EX-1.1 - Verrica Pharmaceuticals Inc. | d361077dex11.htm |
| S-1/A - S-1/A - Verrica Pharmaceuticals Inc. | d361077ds1a.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Verrica Pharmaceuticals Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Richmond, Virginia
June 4, 2018